FDA Greenlights Twice-A-Year HIV Prevention Drug

FDA Greenlights Twice-A-Year HIV Prevention Drug

By Antonio Pequeño IV – Forbes – Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir)...